| __timestamp | Lantheus Holdings, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 176081000 | 9216000000 |
| Thursday, January 1, 2015 | 157939000 | 8296000000 |
| Friday, January 1, 2016 | 164073000 | 10044000000 |
| Sunday, January 1, 2017 | 169243000 | 11560000000 |
| Monday, January 1, 2018 | 168489000 | 10558000000 |
| Tuesday, January 1, 2019 | 172526000 | 9351000000 |
| Wednesday, January 1, 2020 | 200649000 | 8933000000 |
| Friday, January 1, 2021 | 237513000 | 8284000000 |
| Saturday, January 1, 2022 | 353358000 | 7952000000 |
| Sunday, January 1, 2023 | 586886000 | 8200000000 |
| Monday, January 1, 2024 | 8480000000 |
Cracking the code
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. Over the past decade, Teva Pharmaceutical Industries Limited and Lantheus Holdings, Inc. have showcased contrasting trends in their cost of revenue.
Teva, a global leader, has seen its cost of revenue fluctuate, peaking in 2017 with a 25% increase from 2014. However, by 2023, costs have decreased by approximately 29%, reflecting strategic cost management.
Conversely, Lantheus has experienced a steady rise, with costs surging by over 230% from 2014 to 2023. This growth mirrors their expanding market presence and investment in innovative solutions.
While Teva focuses on optimizing costs, Lantheus is investing in growth. These trends highlight the diverse strategies within the pharmaceutical sector, offering valuable insights for investors and industry analysts.
Comparing Cost of Revenue Efficiency: Johnson & Johnson vs Lantheus Holdings, Inc.
Cost of Revenue: Key Insights for AbbVie Inc. and Lantheus Holdings, Inc.
Cost of Revenue Trends: Zoetis Inc. vs Teva Pharmaceutical Industries Limited
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Corcept Therapeutics Incorporated
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Alkermes plc's Expenses
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Lantheus Holdings, Inc.
Cost of Revenue Comparison: Pharming Group N.V. vs Lantheus Holdings, Inc.
Cost of Revenue Comparison: Lantheus Holdings, Inc. vs Grifols, S.A.
Cost Insights: Breaking Down Lantheus Holdings, Inc. and Mesoblast Limited's Expenses
Cost of Revenue Comparison: Lantheus Holdings, Inc. vs Geron Corporation
Comparing Cost of Revenue Efficiency: Lantheus Holdings, Inc. vs BioCryst Pharmaceuticals, Inc.
Cost of Revenue Comparison: Lantheus Holdings, Inc. vs Celldex Therapeutics, Inc.